Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.

Clinical trial NCT03855826 · UNKNOWN

Trial details

NCT number: NCT03855826
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Ventricular Tachycardia Ventricular Fibrillation

Start date: 2019-01-15
Primary completion: 2020-01-30
Enrollment: 756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.